FILTRIX Logo FILTRIX Find Your Edge →

Latest signal:

CRSP Stock Analysis

Data source: Trade-Ideas Alerts | 23 alerts analyzed | Backtest period: 2022-01-24 → 2025-02-14

⚠️ Small sample size (23 alerts). Statistics may have high variance. Interpret with caution.

🏢 Company Profile

📍 NASDAQ 📅 IPO: Oct 19, 2016 🔗 www.crisprtx.com
💰 Market Cap: $5.29B 👥 Employees: 393
Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.
📊
23
Total Alerts
🎯
60.9%
Win Rate (EOD)
💰
+0.09%
Avg Gain (EOD)
🚀
+4.61%
Avg MFE (Max Potential)

📈 Performance by Timeframe

5MIN

Win Rate: 43.5%
Avg Gain: -0.34%
Avg Winner: +1.73%
Avg Loser: -1.94%
Best: +4.37%
Worst: -4.31%
Trades: 10/13

15MIN

Win Rate: 43.5%
Avg Gain: -0.33%
Avg Winner: +3.49%
Avg Loser: -3.27%
Best: +7.74%
Worst: -8.76%
Trades: 10/13

30MIN

Win Rate: 47.8%
Avg Gain: -0.35%
Avg Winner: +3.67%
Avg Loser: -4.39%
Best: +8.37%
Worst: -9.27%
Trades: 11/11

60MIN

Win Rate: 43.5%
Avg Gain: +0.31%
Avg Winner: +5.47%
Avg Loser: -3.66%
Best: +9.97%
Worst: -9.68%
Trades: 10/13

EOD (End of Day)

Win Rate: 60.9%
Avg Gain: +0.09%
Avg Winner: +3.54%
Avg Loser: -5.27%
Best: +10.53%
Worst: -10.72%
Trades: 14/9

🚀 Max Favorable / Adverse Excursion (MFE/MAE)

Institutional-grade metrics showing the maximum profit potential and risk for each alert.

📈 MFE (Max Profit Potential)

Average MFE: +4.61%
Best MFE: +13.12%
Avg Time to MFE: 116 min

On average, CRSP alerts reach +4.61% profit potential within 116 minutes.

📉 MAE (Max Drawdown Risk)

Average MAE: -2.02%
Worst MAE: -7.53%
Avg Time to MAE: 16 min

Before reaching MFE, expect an average drawdown of 2.02%.

⚖️ Risk/Reward Ratio

2.28:1

Excellent risk/reward - potential gain is 2.28x the typical drawdown.

💡 Trading Insight: Based on 23 alerts, CRSP typically reaches +4.61% profit before pulling back. Consider setting profit targets around 3.7% to capture most of the move.

🌅 Premarket Gap Analysis (9:25 → 9:30)

Total Gaps Analyzed 23
Gap Up % 30.4%
Avg Gap -0.17%
Best Gap +1.99%

🏭 Sector Comparison: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

How CRSP compares to 128 other tickers in the same sector.

5-Min Gain
CRSP: -0.34% Sector: -0.41% +0.07%
EOD Gain
CRSP: +0.09% Sector: +1233.50% -1233.41%
Avg MFE
CRSP: +4.61% Sector: +6.69% -2.08%

📋 Last 20 Alerts

Historical CRSP alerts with performance metrics calculated from 1-minute price data. Each row shows the actual price movement at different timeframes after the alert.

Date Time Price 5min 15min 30min 60min EOD MFE MAE Gap Result
2025-02-14 09:27:38 $46.5 +4.37% +7.74% +8.37% +9.97% +6.92% +13.12% -0.99% -0.62% WIN
2025-01-16 09:26:41 $40.33 -0.62% -1.25% -1.02% -1.04% -0.07% +0.87% -2.21% -1.41% LOSS
2024-06-10 09:25:08 $57.46 +0.10% -0.12% - +1.50% +4.40% +4.56% -1.15% -0.80% WIN
2024-02-21 09:27:04 $82.88 -1.04% -4.01% -6.21% -2.37% -0.57% +0.75% -2.27% -0.47% LOSS
2024-02-15 09:29:50 $79.82 +1.06% +3.23% +7.70% +9.66% +5.84% +12.98% -0.68% -0.09% WIN
2024-02-13 09:27:26 $72.5 +1.88% +1.49% +1.21% +1.99% +0.39% +3.70% -0.84% -0.15% WIN
2023-12-14 09:27:00 $62.85 +0.97% -0.17% -2.47% -3.64% +0.14% +1.67% -0.97% -0.02% WIN
2023-12-12 09:26:00 $60.95 -2.80% -2.40% -2.37% -2.31% -4.64% +0.23% -0.33% -0.72% LOSS
2023-12-11 09:27:00 $62.81 -4.31% -7.24% -7.14% -9.68% -4.03% +0.30% -4.19% +0.22% LOSS
2023-12-08 09:25:00 $71.25 -0.14% -0.73% +1.46% +6.74% -9.42% +8.03% -1.92% -0.25% LOSS
2023-11-22 09:26:00 $68.41 +1.09% +2.98% +1.32% +3.00% +3.04% +4.05% -0.60% +0.41% WIN
2023-11-21 09:28:00 $71.4 -2.31% -1.13% -2.56% -3.44% -5.36% +0.84% +0.74% +0.06% LOSS
2023-11-20 09:27:00 $70.22 -1.47% +1.29% +2.95% +5.71% +2.79% +8.50% -3.02% -0.93% LOSS
2023-11-17 09:28:00 $61.42 +0.83% +6.28% +4.19% +5.21% +10.53% +12.24% -1.01% -0.39% WIN
2023-11-16 09:25:00 $58.61 +1.23% -3.12% -3.57% -3.35% +1.04% +3.07% -4.86% -0.94% WIN
2023-11-14 09:25:00 $54.3 +4.26% +1.31% +0.52% -0.82% +1.84% +4.58% -0.37% +1.99% WIN
2023-11-06 09:29:00 $53.33 -1.56% -2.21% -1.28% -1.20% -3.28% +1.15% -3.64% -0.24% LOSS
2023-11-02 09:25:00 $45.62 -1.27% +1.14% +3.00% +3.22% +1.23% +7.01% -3.45% -0.70% LOSS
2023-11-01 09:26:00 $43.0 -3.19% -5.69% -5.12% -1.88% +1.74% +2.70% -7.53% +1.05% LOSS
2023-10-27 09:27:00 $42.74 -3.09% -8.76% -7.32% -8.61% -9.36% +0.88% -0.82% -0.56% LOSS

Table Metrics Explained:

  • 5min/15min/30min/60min/EOD: Price change at each timeframe (calculated from real minute-by-minute data)
  • MFE: Maximum Favorable Excursion - highest profit potential reached during the day
  • MAE: Maximum Adverse Excursion - worst drawdown experienced before reaching MFE
  • Gap: Premarket price gap from 9:25 AM to 9:30 AM market open
  • Result: WIN if 5min change > 0%, LOSS otherwise

🚀 Beat the 60.9% Baseline on CRSP

The 60.9% win rate is just the raw starting point. Launch the app to apply filters (Volume, RSI, Time) and see if you can push CRSP's performance to 75%+.

Optimize CRSP Strategy →

Why Analyze CRSP with FILTRIX?

🛡️ Realistic Entry Simulation

We don't inflate stats. Our analysis tracks only the first alert of the day for CRSP. This simulates a true "Gap & Go" entry at pre-market hours (9:25-9:30 AM), avoiding the trap of chasing a stock that has already extended.

💰 Max Potential (MFE) Analysis

How much is left in the move? On winning days, CRSP historically offers an average upside of +4.61% intraday. Our data helps you distinguish between a quick scalp and a runner.

📊 CRSP Momentum Personality

With a baseline win rate of 60.9%, CRSP shows strong follow-through, making it a prime candidate for momentum strategies.

⏱️ Optimized Exit Timing

Don't guess when to sell. Our backtests show CRSP performs best on the EOD (End of Day) timeframe (Avg Gain: +0.09%), signaling that gains often fade later in the session.